Grommes C, Rubenstein JL, DeAngelis LM, Ferreri AJM, Batchelor TT (2019) Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma. Neuro Oncol 21(3):296–305. https://doi.org/10.1093/neuonc/noy192

Article  PubMed  Google Scholar 

Lv C, Wang J, Zhou M, Xu JY, Chen B, Wan Y (2022) Primary central nervous system lymphoma in the United States, 1975–2017 Ther Adv Hematol 13:20406207211066166. https://doi.org/10.1177/20406207211066166

Ferreri AJ, Reni M, Pasini F, Calderoni A, Tirelli U, Pivnik A, Aondio GM, Ferrarese F, Gomez H, Ponzoni M, Borisch B, Berger F, Chassagne C, Iuzzolino P, Carbone A, Weis J, Pedrinis E, Motta T, Jouvet A, Barbui T, Cavalli F, Blay JY (2002) A multicenter study of treatment of primary CNS lymphoma. Neurology 58:1513–1520. https://doi.org/10.1212/wnl.58.10.1513

Article  CAS  PubMed  Google Scholar 

Stein H, Foss HD, Durkop H, Marafioti T, Delsol G, Pulford K, Pileri S, Falini B (2000) CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features Blood 96:3681–3695

Falini B, Pileri S, Zinzani PL, Carbone A, Zagonel V, Wolf-Peeters C, Verhoef G, Menestrina F, Todeschini G, Paulli M, Lazzarino M, Giardini R, Aiello A, Foss HD, Araujo I, Fizzotti M, Pelicci PG, Flenghi L, Martelli MF, Santucci A (1999) ALK+ lymphoma: clinico-pathological findings and outcome. Blood 93:2697–2706

Feldman AL, Laurent C, Narbaitz M, Nakamura S, Chan WC, de Leval L, Gaulard P (2023) Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas. Virchows Arch 482(1):265–279. https://doi.org/10.1007/s00428-022-03412-6.

Article  CAS  PubMed  Google Scholar 

Ferreri AJ, Govi S, Pileri SA, Savage KJ (2012) Anaplastic large cell lymphoma, ALK-positive. Crit Rev Oncol Hematol 83(2):293–302. https://doi.org/10.1016/j.critrevonc.2012.02.005.

Article  PubMed  Google Scholar 

Kaplan EL, Meier P (1958) Nonparametric-estimation from incomplete observations. J Am Stat Assoc 53:457–481. https://doi.org/10.2307/2281868

Article  Google Scholar 

Sibon D, Bisig B, Bonnet C, Poullot E, Bachy E, Cavalieri D, Fataccioli V, Bregnard C, Drieux F, Bruneau J, Lemonnier F, Dupuy A, Bossard C, Parrens M, Bouabdallah K, Ketterer N, Berthod G, Cairoli A, Damaj G, Tournilhac O, Jais JP, Gaulard P, De Leval L (2023Jun 1) ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study. Haematologica 108(6):1590–1603. https://doi.org/10.3324/haematol.2022.281442

Article  CAS  PubMed  Google Scholar 

Hapgood G, Ben-Neriah S, Mottok A, Lee DG, Robert K, Villa D, Sehn LH, Connors JM, Gascoyne RD, Feldman AL, Farinha P, Steidl C, Scott DW, Slack GW, Savage KJ (2019Aug) Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma. Br J Haematol 186(3):e28–e31. https://doi.org/10.1111/bjh.15860.

Article  PubMed  PubMed Central  Google Scholar 

Parrilla Castellar ER, Jaffe ES, Said JW, Swerdlow SH, Ketterling RP, Knudson RA, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Vasmatzis G, Gibson SE, Ondrejka S, Nicolae A, Grogg KL, Allmer C, Ristow KM, Wilson WH, Macon WR, Law ME, Cerhan JR, Habermann TM, Ansell SM, Dogan A, Maurer MJ, Feldman AL (2014Aug 28) ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood 124(9):1473–1480. https://doi.org/10.1182/blood-2014-04-571091.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pedersen MB, Hamilton-Dutoit SJ, Bendix K, Ketterling RP, Bedroske PP, Luoma IM, Sattler CA, Boddicker RL, Bennani NN, Nørgaard P, Møller MB, Steiniche T, d’Amore F, Feldman AL (2017Jul 27) DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study. Blood 130(4):554–557. https://doi.org/10.1182/blood-2016-12-755496.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qiu L, Tang G, Li S, Vega F, Lin P, Wang SA, Wang W, Iyer SP, Malpica L, Miranda RN, Konoplev S, Tang Z, Fang H, Medeiros LJ, Xu J (2023Jun 1) DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma. Haematologica 108(6):1604–1615. https://doi.org/10.3324/haematol.2022.281222

Article  CAS  PubMed  Google Scholar 

Menon MP, Nicolae A, Meeker H, Raffeld M, Xi L, Jegalian AG, Miller DC, Pittaluga S, Jaffe ES (2015) Primary CNS T-cell lymphomas: a clinical, morphologic, immunophenotypic, and molecular analysis Am J Surg Pathol 39:1719–1729. https://doi.org/10.1097/PAS.0000000000000503

Giannini C, Dogan A, Salomao DR (2014) CNS lymphoma: a practical diagnostic approach. J Neuropathol Exp Neurol 73:478–494. https://doi.org/10.1097/NEN.0000000000000076

Article  CAS  PubMed  Google Scholar 

Benharroch D, Meguerian-Bedoyan Z, Lamant L, Amin C, Brugieres L, Terrier-Lacombe MJ, Haralambieva E, Pulford K, Pileri S, Morris SW, Mason DY, Delsol G (1998) ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 91:2076–2084

Article  CAS  PubMed  Google Scholar 

Roetzer T, Furtner J, Gesperger J, Seebrecht L, Bandke D, Brada M, Brandner-Kokalj T, Grams A, Haybaeck J, Kitzwoegerer M, Leber SL, Marhold F, Moser P, Sherif C, Trenkler J, Unterluggauer J, Weis S, Wuertz F, Hainfellner JA, Langs G, Nenning KH, Woehrer A (2020) Sex-specific differences in primary CNS lymphoma cancers (Basel) 12. https://doi.org/10.3390/cancers12061593

Ferry JA, A FJ, ScienceDirect, (2011) Extranodal lymphomas. Elsevier/Saunders, Philadelphia

Google Scholar 

Hirano Y, Miyawaki S, Tanaka S, Taoka K, Hongo H, Teranishi Y, Takami H, Takayanagi S, Kurokawa M, Saito N (2021) Clinical features and prognostic factors for primary anaplastic large cell lymphoma of the central nervous system: a systematic review cancers (Basel) 13. https://doi.org/10.3390/cancers13174358

Pina-Oviedo S, Ortiz-Hidalgo C, Carballo-Zarate AA, Zarate-Osorno A (2021) ALK-negative anaplastic large cell lymphoma: current concepts and molecular pathogenesis of a heterogeneous group of large t-cell lymphomas cancers (Basel) 13. https://doi.org/10.3390/cancers13184667

Crescenzo R, Abate F, Lasorsa E, Tabbo' F, Gaudiano M, Chiesa N, Di Giacomo F, Spaccarotella E, Barbarossa L, Ercole E, Todaro M, Boi M, Acquaviva A, Ficarra E, Novero D, Rinaldi A, Tousseyn T, Rosenwald A, Kenner L, Cerroni L, Tzankov A, Ponzoni M, Paulli M, Weisenburger D, Chan WC, Iqbal J, Piris MA, Zamo' A, Ciardullo C, Rossi D, Gaidano G, Pileri S, Tiacci E, Falini B, Shultz LD, Mevellec L, Vialard JE, Piva R, Bertoni F, Rabadan R, Inghirami G (2015) European T-Cell Lymphoma Study Group, T-Cell Project: Prospective Collection of Data in Patients with Peripheral T-Cell Lymphoma and the AIRC 5xMille Consortium “Genetics-Driven Targeted Management of Lymphoid Malignancies”. Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell 27(4):516–32. https://doi.org/10.1016/j.ccell.2015.03.006.

Magaki S, Satyadev R, Chen Z, Yung KS, Vinters HV, Kinney MC, Said JW (2022) Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement Brain Tumor Pathol 39:25–34. https://doi.org/10.1007/s10014-021-00415-0